A Proof of Concept and Dose Ranging Study in Patients With Rheumatoid Arthritis

NCT00713544 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

373

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: AZD5672
DRUG: Etanercept
DRUG: Placebo
DRUG: AZD5672
DRUG: AZD5672
DRUG: AZD5672

Sponsor

AstraZeneca